Oncology

Chemotherapy Use Declines for Breast Cancer Patients

With growing concern about overtreatment of breast cancer as outcomes have improved over time, not much research has been performed on how chemotherapy use and oncologists’ recommendations have changed in recent years.

Laparoscopic, Robotic Surgeries Equivalent for Pancreatic Cancer

Pancreatic cancer patients increasingly are receiving minimally invasive pancreaticoduodenectomy (MIPD).

Advanced NSCLC Patients Still Receive Aggressive Treatment

Aggressive care for cancer patients appears to be increasing at the end of life, and the VA is part of that trend, according to a new study.

Survey Results Add to Information About ECP Treatment for CTCL

LEBANON, NH — Extracorporeal photopheresis (ECP) is a leukapheresis-based therapeutic procedure that has been approved by the Food and Drug Administration (FDA) for the treatment of advanced cutaneous T-cell lymphoma (CTCL) since 1988. In ECP, white blood cells are collected… Read More

New Treatment Option Extends CTCL Progression Free Survival

STANFORD, CA — Patients with cutaneous T-cell lymphoma (CTCL) might have a promising new treatment option, according to a study presented at a recent conference. In a presentation at the 2017 American Society of Hematology Annual Meeting in Atlanta, an… Read More

Agent Orange Exposure Doesn’t Reduce CLL Survival

MINNEAPOLIS—Exposure to Agent Orange was not associated with either poor prognostic factors or shortened overall survival in a large veteran population with chronic lymphocytic leukemia (CLL), even though it is associated with development of the disease, according to a study… Read More

Video-assisted Thoracoscopic Lobectomy Improves NSCLC Survival

Should stereotactic body radiotherapy remain the standard treatment for medically inoperable early-Stage non-small cell lung cancer?

Metformin Shows Promise for Increasing NSCLC Survival

BETHESDA, MD—Past research has raised the possibility that a common blood sugar-lowering drug could be associated with improved survival in cancer patients with Type 2 diabetes. A study published recently in the International Journal of Cancer assessed whether metformin use is associated… Read More

New Techniques Improved Survival for Veterans with Stage 1 NSCLC

Improved radiation and surgical techniques boosted overall survival in veterans diagnosed with Stage I non-small cell lung cancer (NSCLC) from 2001 to 2010.

Factors Affecting Biochemical Recurrence of Prostate Cancer

DURHAM, NC—What is the association between lowest prostate-specific antigen (PSA) and time to nadir with biochemical recurrence (BCR) risk after radical prostatectomy (RP)? A study published recently in the journal Urology used the SEARCH database to try to answer that… Read More

Visceral Metastases Predict Overall PC Survival in Veterans

DURHAM, NC—Visceral metastases (VMs) are generally believed to predict worse prognoses compared with bone and lymph metastases in men with metastatic castration-resistant prostate cancer (mCRPC). Still, a new study published in the journal European Urology Focus pointed out that not… Read More

Veterans With PTSD Fare Worse With Concurrent Prostate Cancer

EAST NORTHPORT, NY—Being diagnosed with prostate cancer can be difficult enough. But what happens when the patient also is a veteran with post-traumatic stress disorder (PTSD)? A presentation at the 2017 American Society of Clinical Oncology explored that question.1 A… Read More

VA Researcher Works to Find Improved Therapies for Esophageal Cancer

VA Researcher Works to Find Improved Therapies for Esophageal Cancer

By Stephen Spotswood BALTIMORE—James Donahue, MD, has been thinking about the need for better treatments for cancer his entire adult life. His mother died from breast cancer when he was 14, and from that day forward his course has been… Read More

Viagra Likely Doesn’t Cause Melanoma Cases

NEW YORK—A new study found higher rates of melanoma in users of the erectile dysfunction drug Viagra but could identify no direct cause and effect. A report published online by the Journal of the National Cancer Institute instead attributes the… Read More

VA Researchers Show How Imatinib Improves Prognosis for Hard-to-Treat Cancer

VA Researchers Show How Imatinib Improves Prognosis for Hard-to-Treat Cancer

PORTLAND, OR — Not long ago, less than a third of chronic myeloid leukemia (CML) patients survived five years and gastrointestinal stromal tumor (GIST) patients had an even shorter life expectancy, according to the National Cancer Institute. Now significant numbers of patients with these cancers live for another 10 years after diagnosis.

Stereotactic Body Radiation Doubles Lung Cancer Survival in Some Veterans

Stereotactic Body Radiation Doubles Lung Cancer Survival in Some Veterans

Between 2001 and 2010, survival rates for early-stage non-small cell lung cancer (NSCLC) doubled among veterans.

IBM’s Watson Expands Access to Precision Medicine for Veterans With Cancer

IBM’s Watson Expands Access to Precision Medicine for Veterans With Cancer

While Dr. Watson of Sherlock Holmes fame often missed the critical clue, the VA expects its new partnership with IBM’s Watson to help it detect the genomic fingerprints of cancer and make effective treatments less of a mystery.

Rules Keep Some VA Cancer Patients from Receiving Concurrent Care in Hospice

Rules Keep Some VA Cancer Patients from Receiving Concurrent Care in Hospice

According to VHA rules, veterans with cancer need not make the “terrible choice” between receiving therapies to combat their illness or hospice services.

Impetigo, Psoriasis Might Increase Cutaneous T-Cell Lymphoma Risk

Impetigo, Psoriasis Might Increase Cutaneous T-Cell Lymphoma Risk

Recent research has focused on some etiological factors to help predict who is at risk for developing cutaneous T-cell lymphoma (CTCL), which occurs disproportionately in veterans.

Final Agent Orange Report: Stronger Link to Bladder Cancer, Hypothyroidism

Final Agent Orange Report: Stronger Link to Bladder Cancer, Hypothyroidism

The Institute of Medicine (IOM) changed the classification of three medical conditions in its last congressionally-ordered review of the evidence of health problems associated with exposure to Agent Orange and other herbicides during the Vietnam War.